The myth of stability in heart failure: the danger of treatment delay

Back

Open Access

The myth of stability in heart failure: the danger of treatment delay

Session: An optimal chance of success: heart failure therapy for outpatients

Topic: Pharmacotherapy

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Sponsored by the Boehringer Ingelheim and Lilly Alliance

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Shelley Zieroth

University of Manitoba, Winnipeg (Canada)

55 presentations

3 followers

5 more presentations in this session

Welcome and introduction

Speaker: Doctor M. Costanzo (Naperville, US)

Access

Slides

Video

From guidelines to clinical practice: how far have we come?

Speaker: Professor N. Marx (Aachen, DE)

Access

Slides

Video

Spotlight on HFpEF: you can't diagnose what you don't see

Speaker: Professor M. Boehm (Homburg, DE)

Access

Slides

Video

A broader benefit: from heart failure to wider cardio-renal-metabolic (CRM) conditions

Speaker: Doctor P. Campbell (Portadown, GB)

Access

Slides

Video

Audience questions and close

Speaker: Doctor M. Costanzo (Naperville, US)

Access

Slides

Video

Access the full session

An optimal chance of success: heart failure therapy for outpatients

Speakers: Doctor S. Zieroth, Doctor M. Costanzo, Professor N. Marx, Professor M. Boehm, Doctor P. Campbell...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources